| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/09/2002 | EP1169336A1 Ent-steroids as selectively active estrogens |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169321A2 Purine derivatives having phosphodiesterase iv inhibition activity |
| 01/09/2002 | EP1169316A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 01/09/2002 | EP1169306A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis |
| 01/09/2002 | EP1169302A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169244A2 Metering valve |
| 01/09/2002 | EP1169060A1 Sodium channel blocker compositions and the use thereof |
| 01/09/2002 | EP1169056A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases |
| 01/09/2002 | EP1169054A2 Products and methods for treating ptp lar related diseases |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | EP1169042A1 Dibenzo-azepine derivatives as alpha v integrin receptor antagonists |
| 01/09/2002 | EP1169040A2 Flupirtine in the treatment of fibromyalgia and related conditions |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | EP1169034A1 Decursinol or derivative thereof as analgesic agent |
| 01/09/2002 | EP1169032A1 Ketoprofen microgranules, method for preparing same and pharmaceutical compositions |
| 01/09/2002 | EP1169025A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 01/09/2002 | EP1169005A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 01/09/2002 | EP1168934A1 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 01/09/2002 | EP1168919A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP0996617B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | EP0727978B1 Topical aromatic releasing compositions |
| 01/09/2002 | CN1330718A Therapeutically active proteins in plants |
| 01/09/2002 | CN1330660A Cycle tetrapeptide compound and their use |
| 01/09/2002 | CN1330653A 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 01/09/2002 | CN1330648A 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/09/2002 | CN1330643A IL-5 inhibiting azauracil pyrimidine derivatives |
| 01/09/2002 | CN1330642A N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
| 01/09/2002 | CN1330637A Compounds useful in treatment of infammatory diseases |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/09/2002 | CN1330555A Antibodies to truncated VEGF-D and uses thereof |
| 01/09/2002 | CN1330537A Pharmaceutical mixed comprising profen |
| 01/09/2002 | CN1330067A 1,1-and 1,2-twice subsitituted cyclopropane compound, preparation method thereof and drug composite containing their |
| 01/09/2002 | CN1329916A Chinese medicine for treating rheumatism and rheumatoid diseases |
| 01/09/2002 | CN1329911A Health-care medicinal liquor |
| 01/09/2002 | CN1329896A Medical wine for treating rheumatism, rheumatoid diseases and hyperosteogeny |
| 01/09/2002 | CN1329889A Concentrated granular medicine for treating baby cold and preparation process thereof |
| 01/09/2002 | CN1077568C Phenoxyphenyl cyclopentenyl hydroxyureas |
| 01/09/2002 | CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect |
| 01/09/2002 | CN1077439C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/08/2002 | US6337411 Muscular disorders |
| 01/08/2002 | US6337342 Bis-aryl or heteroaryl indoles |
| 01/08/2002 | US6337325 Combined preparation for the therapy of immune diseases |
| 01/08/2002 | US6337315 Anti-inflammatory compositions comprising peptide derivatives of α-MSH/algal extracts |
| 01/08/2002 | US6337076 Applying onto hypertrophic scar a liquid formulation comprising collodion film-forming carrier having dermatologically effective amount of active ingredient capable of reducing size of scar or improving appearance |
| 01/08/2002 | US6337069 Method of treating rhinitis or sinusitis by intranasally administering a peptidase |
| 01/08/2002 | CA2193087C Topical compositions comprising n-acetyl-l-cysteine |
| 01/08/2002 | CA2150703C Substituted pyrazoles |
| 01/03/2002 | WO2002000887A1 Novel therapeutic molecular variants and uses thereof |
| 01/03/2002 | WO2002000879A2 Methods for producing modified glycoproteins |
| 01/03/2002 | WO2002000877A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |
| 01/03/2002 | WO2002000860A2 Novel proteases |
| 01/03/2002 | WO2002000840A2 Human lyases |
| 01/03/2002 | WO2002000730A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000727A2 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
| 01/03/2002 | WO2002000692A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/03/2002 | WO2002000676A1 Purine derivatives |
| 01/03/2002 | WO2002000664A1 2-aminoalkyl-thieno[2,3-d]pyrimidines |
| 01/03/2002 | WO2002000662A1 Improvements in and relating to chromophores |
| 01/03/2002 | WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| 01/03/2002 | WO2002000658A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 01/03/2002 | WO2002000656A2 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives |
| 01/03/2002 | WO2002000641A2 Spla2 inhibitors |
| 01/03/2002 | WO2002000633A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
| 01/03/2002 | WO2002000631A2 Benzhydryl derivatives |
| 01/03/2002 | WO2002000627A1 A crystalline form of celecoxib |
| 01/03/2002 | WO2002000611A2 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 01/03/2002 | WO2002000609A2 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/03/2002 | WO2002000263A2 Tripeptide prodrug compounds |
| 01/03/2002 | WO2002000227A2 Use of lanthanum compounds for the treatment of bone diseases |
| 01/03/2002 | WO2002000217A1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 01/03/2002 | WO2002000203A1 Topical pharmaceutical formulations and methods of treatment |
| 01/03/2002 | WO2002000195A2 Methods and compositions for treating pain of the mucous membrane |
| 01/03/2002 | WO2002000192A2 Embolization using carbon coated particles |
| 01/03/2002 | WO2002000188A1 Use of inulin and inulin derivatives |
| 01/03/2002 | WO2002000187A1 Use of inulins and inulin derivatives |
| 01/03/2002 | WO2002000172A2 Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| 01/03/2002 | WO2002000167A2 Modified forms of pharmacologically active agents and uses therefor |
| 01/03/2002 | WO2002000017A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/03/2002 | WO2001072669A3 Therapeutic use of polyhydroxy amine derivates |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001051473A8 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 01/03/2002 | WO2001044260A3 Novel purines |
| 01/03/2002 | WO2001032877A3 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 01/03/2002 | WO2000061171A9 Uses of mammalian ox2 protein and related reagents |
| 01/03/2002 | US20020002296 Cytoprotective Compounds |
| 01/03/2002 | US20020002282 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 01/03/2002 | US20020002203 Administering an effective amount of a compound selected from aryl(and heterocyclic) ureido and aryl(heterocyclic) carboxamido phenoxyisobutyric acids as inhibitor of glycation and advanced glycation endproducts (AGEs) (protein-aging) |
| 01/03/2002 | US20020002197 Tropisetron, Fabesetron, Ramosetron and other drugs useful for treatment of a non-inflammatory local disease of the musculo-sceletal system, of a local irritation condition of a joint or tendom sheath or local manifestation |